OKYO Pharma Limited today announced that Okyo Pharma's Chief Medical Officer, Flavio Mantelli, Md, PhD, has purchased 20,000 of the Company'

OKYO Pharma Limited today announced that Okyo Pharma's Chief Medical Officer, Flavio Mantelli, Md, PhD, has purchased 20,000 of the Company's ordinary shares on Nasdaq at $1.40 per share.